Gobert, Aurelien
Spano, Jean-Philippe
Cadranel, Jacques
Funding for this research was provided by:
Institut National Du Cancer
Article History
Received: 3 October 2018
Accepted: 30 October 2018
First Online: 5 December 2018
Compliance with ethical standards
:
: Aurelien Gobert received fees from Pfizer, MSD, Astellas and Roche for participating to board of experts. Jean-Philippe Spano, consultant for Roche and MSD, has received a speaker honorarium from Roche, AZ, MSD, Gilead, Pfizer, BMS, Lilly, PFO, Leopharma and Myriad Genetics. Jacques Cadranel received fees from AZ, BI, BMS, MSD, Novartis Pfizer, Roche and Takeda fort participating to board of experts; received grants for his institution for research programs from AZ, BI, Novartis and Pfizer.
: All procedures performed involving human participants in our study were in accordance with the ethical standards of the Institutional and/or research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards [our group has received an approval from the Commission Nationale de l’Informatique et des Libertés (CNIL), n°16-391].